Free Trial
NASDAQ:TNDM

Tandem Diabetes Care (TNDM) Stock Price, News & Analysis

Tandem Diabetes Care logo
$19.98 +3.13 (+18.58%)
Closing price 04:00 PM Eastern
Extended Trading
$20.19 +0.21 (+1.05%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tandem Diabetes Care Stock (NASDAQ:TNDM)

Key Stats

Today's Range
$18.27
$20.39
50-Day Range
$16.35
$33.59
52-Week Range
$15.75
$53.69
Volume
4.75 million shs
Average Volume
1.52 million shs
Market Capitalization
$1.33 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$39.81
Consensus Rating
Moderate Buy

Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Tandem Diabetes Care Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

TNDM MarketRank™: 

Tandem Diabetes Care scored higher than 93% of companies evaluated by MarketBeat, and ranked 108th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tandem Diabetes Care has received a consensus rating of Moderate Buy. The company's average rating score is 2.53, and is based on 9 buy ratings, 8 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tandem Diabetes Care has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tandem Diabetes Care's stock forecast and price target.
  • Earnings Growth

    Earnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.68) to ($1.20) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tandem Diabetes Care is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tandem Diabetes Care is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tandem Diabetes Care has a P/B Ratio of 4.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.93% of the float of Tandem Diabetes Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Tandem Diabetes Care has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tandem Diabetes Care has recently decreased by 12.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tandem Diabetes Care does not currently pay a dividend.

  • Dividend Growth

    Tandem Diabetes Care does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.93% of the float of Tandem Diabetes Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Tandem Diabetes Care has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tandem Diabetes Care has recently decreased by 12.24%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Tandem Diabetes Care has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 31 news articles for Tandem Diabetes Care this week, compared to 7 articles on an average week.
  • Search Interest

    Only 2 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tandem Diabetes Care insiders have bought more of their company's stock than they have sold. Specifically, they have bought $190,949.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.90% of the stock of Tandem Diabetes Care is held by insiders.

  • Read more about Tandem Diabetes Care's insider trading history.
Receive TNDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter.

TNDM Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

TNDM Stock Analysis - Frequently Asked Questions

Tandem Diabetes Care's stock was trading at $36.02 at the beginning of the year. Since then, TNDM stock has decreased by 44.5% and is now trading at $19.98.
View the best growth stocks for 2025 here
.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) posted its quarterly earnings results on Wednesday, April, 30th. The medical device company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.60) by $0.07. The firm's revenue was up 22.3% compared to the same quarter last year.
Read the conference call transcript
.

Tandem Diabetes Care's stock reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Tandem Diabetes Care's top institutional shareholders include Stephens Investment Management Group LLC (2.56%), Brown Advisory Inc. (1.39%), Principal Financial Group Inc. (0.60%) and Envestnet Asset Management Inc. (0.48%). Insiders that own company stock include Kim D Blickenstaff, Dick Allen, Leigh Vosseller, Jean-Claude Kyrillos, John F Sheridan, Kathleen Mcgroddy-Goetz, Christopher J Twomey, David B Berger, Shannon Marie Hansen, Mark David Novara and Rebecca B Robertson.
View institutional ownership trends
.

Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Alibaba Group (BABA) and Netflix (NFLX).

Company Calendar

Last Earnings
4/30/2025
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TNDM
Fax
N/A
Employees
2,600
Year Founded
2006

Price Target and Rating

Average Stock Price Target
$41.56
High Stock Price Target
$75.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+111.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.53
Research Coverage
17 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-222,610,000.00
Pretax Margin
-14.42%

Debt

Sales & Book Value

Annual Sales
$940.20 million
Price / Cash Flow
N/A
Book Value
$4.81 per share
Price / Book
4.09

Miscellaneous

Free Float
64,232,000
Market Cap
$1.31 billion
Optionable
Optionable
Beta
1.52

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TNDM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners